Dr. Paul Auwaerter – Professor of Medicine at Johns Hopkins University School of Medicine – reviews the latest on Covid-19 transmission, therapy, and vaccination, hosted by Dr. Bill Detmer, CEO of Unbound Medicine.
PRESENTATION
00:00 Introduction
01:29 Update on Covid-19 transmission and mortality
06:08 Covid-19 general approach to therapy (Dexamethasone, Remdesivir)
09:42 Antibody-Based Therapies (Bamlanivimab, Casirivimab + Imdevimab – Regeneron cocktail)
16:25 Convalescent Plasma (Low and High Titer)
22:02 Immunomodulators: Tocilizumab, Baricitinib + Remdesivir)
25:35 Vaccines: mRNA vaccines (BioNTech/Pfizer, Moderna): efficacy and side effects
QUESTION & ANSWER
30:55 Do Covid-19 vaccines cause adverse immune responses?
33:18 If you’ve had Covid, should you get the vaccine?
35:38 Demographics of participants in Covid vaccine clinical trials: how well are groups represented?
37:53 Children: when will we know whether and how they should be vaccinated?
39:55 Vaccine distribution: does everyone need two doses?
42:26 Vaccine distribution: who will get first priority and why?
44:26 Vaccine immunity: how long is it likely to last?
46:58 Wrap up, thanks, and conclusions
FEEDBACK APPRECIATED
webinars@unboundmedicine.com
FOR MORE INFORMATION
Johns Hopkins Antibiotic (ABX) Guide:
Unbound Medicine:
*Pre-recorded and released December 17th, 2020
